Bispecific VH/Fab antibodies targeting neutralizing and non-neutralizing Spike epitopes demonstrate enhanced potency against SARS-CoV-2

Numerous neutralizing antibodies that target SARS-CoV-2 have been reported, and most directly block binding of the viral Spike receptor-binding domain (RBD) to angiotensin-converting enzyme II (ACE2). Here, we deliberately exploit non-neutralizing RBD antibodies, showing they can dramatically assist...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shion A. Lim, Josef A. Gramespacher, Katarina Pance, Nicholas J. Rettko, Paige Solomon, Jing Jin, Irene Lui, Susanna K. Elledge, Jia Liu, Colton J. Bracken, Graham Simmons, Xin X. Zhou, Kevin K. Leung, James A. Wells
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis Group 2021-01-01
Col·lecció:mAbs
Matèries:
Bispecific
neutralizing antibody
knob-in-hole
COVID-19
SARS-CoV-2
Accés en línia:https://www.tandfonline.com/doi/10.1080/19420862.2021.1893426
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars